Sydani Group, a management consulting firm, has indicated interest to partner with the National Institute for Cancer Research and Treatment (NICRAT) in supporting its mandate, especially in meeting the Human Papiloma Virus (HPV) vaccination coverage target and elimination of cervical cancer in Nigeria by 2030.
The Chief Executive Officer (CEO) of Sydani Group, Mr. Sidney Sampson, disclosed this when he led a delegation to pay a courtesy visit to the Director General of NICRAT, Prof. Usman Malami Aliyu, in his office in Abuja, on Tuesday.
Sydani Group is a management consulting firm founded by seasoned international development professionals with over 30 years of combined experience and demonstrated expertise in the design and implementation of diverse impactful sustainable policies, programs, and practices that drive large-scale development.
Some of the key areas of expertise of Sydani Group, he said, include strategy design, data systems optimization, and innovative demand generation.
According to Mr. Sidney, based on NICRAT’s mandate, key areas of potential collaboration include co-creating impactful concepts to drive resource mobilization, leveraging and optimizing existing interventions, collaborating to implement identified opportunities, and providing technical support.
This, he said, will lead to the attainment of the core mandate of NICRAT and support the strengthening of critical areas that have been prioritized for urgent action. He further noted that his team will come back to further discuss specific areas of support to NICRAT, especially, in areas of research.
Speaking, the Director General of NICRAT, Prof. Malami Aliyu, said that the Institute being an agency under the Federal Ministry of Health was established to treat and prevent cancer through massive awareness creation and conduct research across all cancer-related areas.
Prof. Malami expressed confidence in Sydani’s competence and reiterated NICRAT’s willingness to collaborate with a possible Memorandum of Understanding (MoU) to guide the relationship.
He said that the current Human Papilloma Virus (HPV) vaccination currently going on in different parts of the country is aimed at vaccinating eligible young girls from the age of 9 -14 in Nigeria, hence, prevent them from being affected by the disease.
The NICRAT Director General further disclosed that one of the strategies to be adopted to ensure that young girls in the country are prevented from having cervical cancer is the Annual Cervical Cancer Screening Campaign.
This, according to him, is an avenue for women to undergo cervical cancer screening in different parts of the country.
